BCL2 and nasopharyngeal carcinoma: The level of Bcl2 increased by 6.77 and 7.51 times, and Bax decreased by 7.32 and 25.55 times in the groups receiving NPC-CM and GPC-CM, respectively (Figure 2d,e).